H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 105 Citations 134,006 689 World Ranking 3055 National Ranking 15

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Blood pressure
  • Cardiology

Sverre E. Kjeldsen mainly focuses on Internal medicine, Blood pressure, Cardiology, Surgery and Left ventricular hypertrophy. His studies deal with areas such as Stroke and Intensive care medicine as well as Blood pressure. His study in Cardiology is interdisciplinary in nature, drawing from both Ambulatory blood pressure, Losartan and Hazard ratio.

His studies in Ambulatory blood pressure integrate themes in fields like Renal sympathetic denervation and Perindopril/indapamide. Sverre E. Kjeldsen has included themes like Diabetes mellitus, Clinical trial and Atorvastatin in his Surgery study. His Left ventricular hypertrophy study combines topics in areas such as Organ damage, Albuminuria and Isolated systolic hypertension.

His most cited work include:

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (11730 citations)
  • 2007 Guidelines for the Management of Arterial Hypertension : The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (4870 citations)
  • Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. (4860 citations)

What are the main themes of his work throughout his whole career to date?

Sverre E. Kjeldsen mainly investigates Internal medicine, Blood pressure, Cardiology, Endocrinology and Left ventricular hypertrophy. His study looks at the relationship between Internal medicine and topics such as Surgery, which overlap with Denervation. Within one scientific family, Sverre E. Kjeldsen focuses on topics pertaining to Intensive care medicine under Blood pressure, and may sometimes address concerns connected to MEDLINE.

His research in Cardiology intersects with topics in Randomized controlled trial and Hazard ratio. His work on Endocrinology deals in particular with Essential hypertension, Catecholamine, Insulin resistance, Epinephrine and Insulin. The various areas that Sverre E. Kjeldsen examines in his Left ventricular hypertrophy study include Electrocardiography, Albuminuria and Life study.

He most often published in these fields:

  • Internal medicine (84.99%)
  • Blood pressure (53.95%)
  • Cardiology (56.47%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (84.99%)
  • Blood pressure (53.95%)
  • Cardiology (56.47%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Blood pressure, Cardiology, MEDLINE and Stroke. His work in Heart failure, Hazard ratio, Clinical trial, Masked Hypertension and Meta-analysis is related to Internal medicine. The Blood pressure study combines topics in areas such as Denervation, Bedtime, Randomized controlled trial, Emergency medicine and Myocardial infarction.

His Cardiology study incorporates themes from Valsartan and Intervention trial. His work carried out in the field of MEDLINE brings together such families of science as Pharmacotherapy and Intensive care medicine. His research integrates issues of Body mass index, Cardiorespiratory fitness, Cause of death and Weight change in his study of Stroke.

Between 2017 and 2021, his most popular works were:

  • 2018 ESC/ESH Guidelines for the management of arterial hypertension. (2415 citations)
  • 2018 ESC/ESH Guidelines for the management of arterial hypertension : The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension (801 citations)
  • 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension (234 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Blood pressure
  • Cardiology

The scientist’s investigation covers issues in Blood pressure, Internal medicine, Cardiology, MEDLINE and Valsartan. His Blood pressure research incorporates themes from Denervation, Kidney, Proportional hazards model, Pill and Risk factor. His Kidney research is multidisciplinary, incorporating perspectives in Surgery and Heart rate.

His biological study spans a wide range of topics, including Hyperintensity and Sprint. He studies Atrial fibrillation, a branch of Cardiology. His work in the fields of MEDLINE, such as Hypertension diagnosis, intersects with other areas such as Task force.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon.
European Heart Journal (2013)

15247 Citations

2007 Guidelines for the management of arterial hypertension

Giuseppe Mancia;Guy De Backer;Anna Dominiczak;Renata Cifkova.
European Heart Journal (2007)

15171 Citations

2007 Guidelines for the Management of Arterial Hypertension : The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Giuseppe Mancia;Guy De Backer;Anna Dominiczak;Renata Cifkova.
Journal of Hypertension (2007)

14156 Citations

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon.
Journal of Hypertension (2013)

8250 Citations

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Björn Dahlöf;Richard B Devereux;Sverre E Kjeldsen;Stevo Julius.
The Lancet (2002)

7332 Citations

2018 ESC/ESH Guidelines for the management of arterial hypertension.

Bryan Williams;Giuseppe Mancia;Wilko Spiering;Enrico Agabiti Rosei.
European Heart Journal (2018)

5146 Citations

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter S Sever;Björn Dahlöf;Neil R Poulter;Hans Wedel.
The Lancet (2003)

4467 Citations

2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension

G Mancia;EA Rosei;R Cifkova;G DeBacker.
web science (2003)

4270 Citations

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

Stevo Julius;Sverre E Kjeldsen;Michael Weber;Hans R Brunner.
The Lancet (2004)

3653 Citations

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

Björn Dahlöf;Peter S Sever;Neil R Poulter;Hans Wedel.
The Lancet (2005)

3249 Citations

Editorial Boards

Blood Pressure
(Impact Factor: 1.771)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Sverre E. Kjeldsen

Giuseppe Mancia

Giuseppe Mancia

University of Milano-Bicocca

Publications: 454

Luis M. Ruilope

Luis M. Ruilope

European University of Madrid

Publications: 325

Massimo Volpe

Massimo Volpe

Sapienza University of Rome

Publications: 308

Guido Grassi

Guido Grassi

University of Milano-Bicocca

Publications: 280

Jan A. Staessen

Jan A. Staessen

KU Leuven

Publications: 261

Gianfranco Parati

Gianfranco Parati

University of Milano-Bicocca

Publications: 250

Roland E. Schmieder

Roland E. Schmieder

University of Erlangen-Nuremberg

Publications: 231

Kazuomi Kario

Kazuomi Kario

Jichi Medical University

Publications: 213

George L. Bakris

George L. Bakris

University of Chicago

Publications: 193

Takayoshi Ohkubo

Takayoshi Ohkubo

Teikyo University

Publications: 185

Josep Redon

Josep Redon

University of Valencia

Publications: 174

Alberto Zanchetti

Alberto Zanchetti

University of Milan

Publications: 167

Gregory Y.H. Lip

Gregory Y.H. Lip

University of Liverpool

Publications: 166

Markus P. Schlaich

Markus P. Schlaich

University of Western Australia

Publications: 157

Ji-Guang Wang

Ji-Guang Wang

Shanghai Jiao Tong University

Publications: 155

Yutaka Imai

Yutaka Imai

Tohoku University

Publications: 151

Something went wrong. Please try again later.